MSUK wrote:Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results
BACKGROUND: Clinical trials established the efficacy and safety of natalizumab. Data are needed over longer periods of time and in the clinical practice setting..... Read More -http://www.ms-uk.org/tysabri
grandsons4 wrote:Perhaps they hadn't yet reached the minimum two-year threshold reported on.
CureOrBust wrote:I think the missing numbers may be partially made up of those that came up as JCV positive, and hence advised to stop taking it, but not "technically" being diagnosed or suffer specific JCV symptoms.
Users browsing this forum: No registered users